United States · FDA National Drug Code directory
Cetirizine hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62207-764_5691298e-b03a-ccb8-e063-6394a90ae113
- Product NDC
- 62207-764
- Form
- TABLET, COATED
- Composition / generic term
- Cetirizine hydrochloride
- Labeler
- Granules India Ltd
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180528
- Source listing expiry
- 20271231
Source-listed ingredients
- CETIRIZINE HYDROCHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1000 TABLET, COATED in 1 BOTTLE (62207-764-49) · 62207-764-49
- 14 TABLET, COATED in 1 BOTTLE (62207-764-55) · 62207-764-55
- 13 BLISTER PACK in 1 CARTON (62207-764-73) / 10 TABLET, COATED in 1 BLISTER PACK · 62207-764-73
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →